Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods
Abstract Cancer immunotherapy has emerged as the fourth most prevalent approach to tumor treatment, alongside surgery, radiotherapy, and chemotherapy. After several decades of development, chimeric antigen receptor T (CAR‐T) cell therapy, a promising branch of adoptive T‐cell therapy, has demonstrat...
Saved in:
| Main Authors: | Bo Zou, Yanzhou Song, Ning Li, Zhongyi Fan, Jie Li, Yuanzheng Peng, Wanshan Wei, Yuzi Zhang, Yinan Su, Xianmin Meng, Hongzhou Lu, Xingding Zhang, Xiaohua Tan, Qibin Liao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | iLabmed |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ila2.31 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advance in chimeric antigen receptor T therapy in autoimmune diseases
by: Xiaolan Ji, et al.
Published: (2025-03-01) -
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01) -
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01) -
The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
by: Ruonan Yu, et al.
Published: (2025-04-01) -
Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors
by: Bo Zou, et al.
Published: (2025-04-01)